These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 12435517)

  • 41. FDA notifications. Renal impairment addressed in labeling.
    AIDS Alert; 2011 Nov; 26(11):131. PubMed ID: 22164522
    [No Abstract]   [Full Text] [Related]  

  • 42. Phototherapy, photochemotherapy, and photodynamic therapy: unapproved uses or indications.
    Ledo E; Ledo A
    Clin Dermatol; 2000; 18(1):77-86. PubMed ID: 10701088
    [No Abstract]   [Full Text] [Related]  

  • 43. Antimalarials: unapproved uses or indications.
    Wolf R; Wolf D; Ruocco V
    Clin Dermatol; 2000; 18(1):17-35. PubMed ID: 10701084
    [No Abstract]   [Full Text] [Related]  

  • 44. Dapsone: unapproved uses or indications.
    Wolf R; Tüzün B; Tüzün Y
    Clin Dermatol; 2000; 18(1):37-53. PubMed ID: 10701085
    [No Abstract]   [Full Text] [Related]  

  • 45. An EUA for bamlanivimab - a monoclonal antibody for COVID-19.
    Med Lett Drugs Ther; 2020 Nov; 62(1612):185-186. PubMed ID: 33443490
    [No Abstract]   [Full Text] [Related]  

  • 46. Unapproved uses of approved drugs: the physician, the package insert, and the Food and Drug Administration: subject review. American Academy of Pediatrics Committee on Drugs.
    Pediatrics; 1996 Jul; 98(1):143-5. PubMed ID: 8668390
    [TBL] [Abstract][Full Text] [Related]  

  • 47. FDA panel unanimously recommends approval of Vistide for CMV retinitis. Food and Drug Administration.
    J Int Assoc Physicians AIDS Care; 1996 May; 2(5):50. PubMed ID: 11363532
    [TBL] [Abstract][Full Text] [Related]  

  • 48. FOLFOX for stage II colon cancer? A commentary on the recent FDA approval of oxaliplatin for adjuvant therapy of stage III colon cancer.
    Grothey A; Sargent DJ
    J Clin Oncol; 2005 May; 23(15):3311-3. PubMed ID: 15908645
    [No Abstract]   [Full Text] [Related]  

  • 49. Antibiotics: unapproved uses or indications.
    Sadick NS
    Clin Dermatol; 2000; 18(1):11-6. PubMed ID: 10701083
    [No Abstract]   [Full Text] [Related]  

  • 50. Once-daily Kaletra approved.
    AIDS Patient Care STDS; 2005 Jul; 19(7):467. PubMed ID: 16053404
    [No Abstract]   [Full Text] [Related]  

  • 51. Trends in clinical development timeframes for antiviral drugs launched in the UK, 1981-2014: a retrospective observational study.
    Ward DJ; Hammond E; Linden-Phillips L; Stevens AJ
    BMJ Open; 2015 Nov; 5(11):e009333. PubMed ID: 26576812
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Analysis of combinations of antiviral drugs and design of effective multidrug therapies.
    Prichard MN; Shipman C
    Antivir Ther; 1996 Jan; 1(1):9-20. PubMed ID: 11322261
    [No Abstract]   [Full Text] [Related]  

  • 53. Optimal control of drug therapy: melding pharmacokinetics with viral dynamics.
    Yang Y; Xiao Y; Wang N; Wu J
    Biosystems; 2012 Mar; 107(3):174-85. PubMed ID: 22172775
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A Review of Patient-Reported Outcomes Labeling for Oncology Drugs Approved by the FDA and the EMA (2012-2016).
    Gnanasakthy A; Barrett A; Evans E; D'Alessio D; Romano CD
    Value Health; 2019 Feb; 22(2):203-209. PubMed ID: 30711065
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Tense Bullae on the Penile Shaft: Answer.
    Laurain D; Seminario-Vidal L; Rodriguez-Waitkus P; Shenefelt P
    Am J Dermatopathol; 2017 Nov; 39(11):870. PubMed ID: 29053549
    [No Abstract]   [Full Text] [Related]  

  • 56. Oral treatment for hepatitis B gets approval in the United States.
    Josefson D
    BMJ; 1998 Oct; 317(7165):1034. PubMed ID: 9841038
    [No Abstract]   [Full Text] [Related]  

  • 57. Embedding evolutionary game theory into an optimal control framework for drug dosage design.
    Bewick S; Yang R; Zhang M
    Annu Int Conf IEEE Eng Med Biol Soc; 2009; 2009():6026-9. PubMed ID: 19964147
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Fever and cutaneous lesions in leg in a 20 month-old girl].
    Gamo Villegas R; Guerra Tapia A; Iglesias Díez L
    Rev Clin Esp; 2003 Jun; 203(6):307-8. PubMed ID: 12783721
    [No Abstract]   [Full Text] [Related]  

  • 59. A combination of ledipasvir and sofosbuvir (Harvoni) for hepatitis C.
    Med Lett Drugs Ther; 2014 Nov; 56(1455):111-2. PubMed ID: 25372848
    [No Abstract]   [Full Text] [Related]  

  • 60. Cutaneous manifestations of systemic viral diseases in neonates: an update.
    Castillo SA; Pham AK; Dinulos JG
    Curr Opin Pediatr; 2017 Apr; 29(2):240-248. PubMed ID: 28134705
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.